| For: | Devi J, Raees A, Butt AS. Redefining non-alcoholic fatty liver disease to metabolic associated fatty liver disease: Is this plausible? World J Hepatol 2022; 14(1): 158-167 [PMID: 35126845 DOI: 10.4254/wjh.v14.i1.158] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v14/i1/158.htm |
| Number | Citing Articles |
| 1 |
Maria Hernandez-Tejero, Samhita Ravi, Jaideep Behari, Gavin E. Arteel, Juan Pablo Arab, Ramon Bataller. High Variability on Alcohol Intake Threshold in Articles Using the MAFLD Acronym. Gastro Hep Advances 2024; 3(1) doi: 10.1016/j.gastha.2023.08.016
|
| 2 |
Xue Wang, Jinlong You, Jing Tang, Xiuqian Li, Rui Wang, Yuanyuan Li, Chun Yin, Yana Bai, Minzhen Wang, Shan Zheng. Is MAFLD better than NAFLD in predicting the risk of major cardiovascular diseases? Evidence from a 7-year prospective cohort study. Nutrition, Metabolism and Cardiovascular Diseases 2025; 35(3) doi: 10.1016/j.numecd.2024.103799
|
| 3 |
Ornella Rotolo, Caterina Bonfiglio, Rosa Reddavide, Anna Maria Cisternino, Rosa Inguaggiato, Gianluigi Giannelli. The Effect of a Four-Month Low-Carbohydrate Diet on Visceral Adipose Tissue in Obese Subjects with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Nutrients 2025; 17(17) doi: 10.3390/nu17172905
|
| 4 |
Arkiath Veettil Raveendran. Type 2 diabetes mellitus: Isn’t it time to update the terminology?. World Journal of Diabetes 2025; 16(9): 107517 doi: 10.4239/wjd.v16.i9.107517
|
| 5 |
D. Yu. Venidiktova, A. V. Borsukov. Instrumental features of the differential diagnosis of metabolically associated and non-alcoholic fatty liver diseases. The Siberian Journal of Clinical and Experimental Medicine 2023; 38(2) doi: 10.29001/2073-8552-2023-38-2-209-217
|
| 6 |
Seiji Nomura, Lixiang Wang, Nao Hasuzawa, Ayako Nagayama, Sawako Moriyama, Kenji Ashida, Yoshinori Moriyama, Masatoshi Nomura, Ken Yamamoto. Imeglimin attenuates liver fibrosis by inhibiting vesicular ATP release from hepatic stellate cells. FEBS Letters 2025; 599(23) doi: 10.1002/1873-3468.70166
|
| 7 |
Anna Di Sessa, Emanuele Miraglia del Giudice, Pierluigi Marzuillo, Josè Alberto D'Anna, Alessandra Salvatori, Elisabetta D'Addio, Stefano Guarino, Francesca Lanzaro. Metabolic-associated fatty liver disease from childhood to adulthood: State of art and future directions. World Journal of Hepatology 2022; 14(6): 1087-1098 doi: 10.4254/wjh.v14.i6.1087
|
| 8 |
Georgiana-Andreea Marinescu, Alexandra-Daniela Rotaru-Zavaleanu, Emil-Tiberius Trasca, Elena-Irina Caluianu, Oana Taisescu, Andrei Gresita, Madalina Iuliana Musat, Dumitru Radulescu, Razvan Mercut, Citto-Iulian Taisescu. Hydrogel-Based Therapeutic Strategies for Post-Cholecystectomy NAFLD: Targeting Bile Acid Signaling, Gut Microbiota, Inflammation, and Hepatic Fibrosis. Gels 2026; 12(2) doi: 10.3390/gels12020179
|
| 9 |
Marina Jara Vidal, Javier Torres Hernández, Marta Gallach Martínez, Andrés Ruíz de Assín Valverde, Laura Navarro Casado, Pedro J. Pinés Corrales. Prevalence of liver fibrosis index-4 (FIB-4) positive results in patients with diabetes. Medicina Clínica (English Edition) 2025; 165(2) doi: 10.1016/j.medcle.2025.106981
|
| 10 |
Wei Fu, Xiaoyue Wu, Guobin Cheng, Linya Lyu, Hulin Wang. Association between the Zhejiang University index and metabolic dysfunction-associated fatty liver disease as analyzed in National Health and Nutrition Examination Survey: A retrospective observational study. Journal of International Medical Research 2026; 54(3) doi: 10.1177/03000605261431613
|
| 11 |
Weiwei He, Caoxin Huang, Liying Wang, Weijuan Su, Shunhua Wang, Peiying Huang, Xiaofang Zhang, Yinxiang Huang, Yan Zhao, Mingzhu Lin, Xiulin Shi, Xuejun Li. The correlation between triiodothyronine and the severity of liver fibrosis. BMC Endocrine Disorders 2022; 22(1) doi: 10.1186/s12902-022-01228-8
|
| 12 |
Sharon Olabisoye Oladipupo, Emmanuel Henry Ezenabor, Adebola Busola Ojo, Akingbolabo Daniel Ogunlakin, Oluwafemi Adeleke Ojo. Interplay of the pathophysiological mechanisms of non-alcoholic fatty liver disease, diabetes mellitus, and inflammation: A growing threat to public health. Obesity Medicine 2025; 55 doi: 10.1016/j.obmed.2025.100613
|
| 13 |
Charilila-Loukia Ververeli, Yannis Dimitroglou, Stergios Soulaidopoulos, Evangelos Cholongitas, Constantina Aggeli, Konstantinos Tsioufis, Dimitris Tousoulis. Cardiac Remodeling and Arrhythmic Burden in Pre-Transplant Cirrhotic Patients: Pathophysiological Mechanisms and Management Strategies. Biomedicines 2025; 13(4) doi: 10.3390/biomedicines13040812
|
| 14 |
Marina Jara Vidal, Javier Torres Hernández, Marta Gallach Martínez, Andrés Ruíz de Assín Valverde, Laura Navarro Casado, Pedro J. Pinés Corrales. Prevalence of liver fibrosis index-4 (FIB-4) positive results in patients with diabetes. Medicina Clínica 2025; 165(2) doi: 10.1016/j.medcli.2025.106981
|
| 15 |
Ghazala S Virk, Jaahnavi Vajje, Nausheen K Virk, Raam Mannam, Wajeeh Rehman, Naglaa G Ghobriel , Irfan-ud-din Mian, Muhammad Usama. Comparison of Outcomes Between Metabolic Dysfunction-Associated Fatty Liver Disease and Non-alcoholic Fatty Liver Disease: A Meta-Analysis. Cureus 2023; doi: 10.7759/cureus.44413
|